You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-839-ESGO Recurrence of endometrial carcinoma: diagnosis in asymptomatic phase compared with symptomatic recurrence. Does it have any impact?

Citation Tools

Article menu

Download PDFPDF

Endometrial cancer
2022-RA-839-ESGO Recurrence of endometrial carcinoma: diagnosis in asymptomatic phase compared with symptomatic recurrence. Does it have any impact?
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Rodriguez Garnica MD, Gónzalez EL, Berrio RG, et al
2022-RA-839-ESGO Recurrence of endometrial carcinoma: diagnosis in asymptomatic phase compared with symptomatic recurrence. Does it have any impact?
International Journal of Gynecologic Cancer 2022;32:A114.